Related Experiment Video
Updated: Jul 4, 2026
08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Identification of the Novel HLA-A*01:510 Allele Through Next-Generation Sequencing
Emerson Fernando Garcia Machado1,2, Josiane Aparecida Linhares1, Maria Eduarda Dugonski1
1Laboratory of Immunogenetics, Cajuru University Hospital, Curitiba, Parana, Brazil.
HLA
|July 3, 2026
Summary
A novel Human Leukocyte Antigen (HLA) allele, HLA-A*01:510, has been identified. This new HLA allele differs from a common variant by a single non-synonymous substitution in exon 5.
Area of Science:
- Immunogenetics
- Molecular Biology
- Human Leukocyte Antigen (HLA) research
Background:
- The Human Leukocyte Antigen (HLA) system is crucial for immune response.
- Polymorphisms in HLA genes contribute to immune diversity and disease susceptibility.
- Accurate HLA typing is essential for transplantation and disease association studies.
Purpose of the Study:
- To report the characterization of a novel HLA-A allele.
- To provide detailed information on the genetic variation within the HLA-A locus.
Main Methods:
- High-resolution HLA typing was performed.
- Sequence analysis was used to identify variations in the HLA-A gene.
Main Results:
- A new HLA allele, designated HLA-A*01:510, was discovered.
- This allele differs from HLA-A*01:01:01:01 by a single nucleotide polymorphism (SNP) in exon 5.
- The substitution is non-synonymous, leading to an amino acid change.
Conclusions:
- The discovery of HLA-A*01:510 expands the known HLA allele repertoire.
- This finding contributes to a more comprehensive understanding of HLA polymorphism.
- Further studies may investigate the functional or clinical implications of this novel allele.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.